MarketLens
Sign Up

Has Amphastar Pharmaceuticals Bottomed Out After Its Steep Decline

6 months ago
SHARE THIS ON:

Has Amphastar Pharmaceuticals Bottomed Out After Its Steep Decline

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 weeks ago

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

Analysts estimate Amphastar Pharmaceuticals (AMPH) will report a decline in earnings for its upcoming quarter, as the company lacks the combination of factors typically needed for an earnings beat.
Stock News•1 months ago

Down 25% in 4 Weeks, Here's Why You Should You Buy the Dip in Innate Pharma (IPHA)

Innate Pharma (IPHA) fell 25% in four weeks, leaving the stock technically oversold as heavy selling pressure appears to exhaust. Wall Street analysts are revising earnings estimates higher, which cou...
Stock News•1 months ago

Pharming Group: Viable Contrarian Buy If Ruconest Stabilizes

Pharming Group's RUCONEST revenue showed a sequential sales rebound, but oral competition could challenge stabilization. The bull case assumes manageable issues, potentially buying time for Joenja to ...

Breaking News

View All →

Top Headlines

View More →
Stock News•19 minutes ago

Nvidia (NVDA) Q3 Earnings and Revenues Beat Estimates

Stock News•22 minutes ago

Nvidia is abandoning China after Jensen Huang's ouster

Stock News•29 minutes ago

Nvidia: Blowout Earnings, Huge Guidance, Insane 0.2x PEG

Stock News•36 minutes ago

Nvidia Results Show Resilience, New Street's Chkaiban Says

Stock News•37 minutes ago

Nvidia Delivers Solid Outlook in First Post-Huang Earnings